APA (7th ed.) Citation

H, W., L, G., GM, H., S, S., D, H., T, C., & MR, N. (2025). Elevated plasma CXCL9 and CHI3L1 prior to HCT predict post-HCT lung complications in children. Clinical & translational immunology, 14(12), e70064. https://doi.org/10.1002/cti2.70064

Chicago Style (17th ed.) Citation

H, Walker, Gubbels L, Haeusler GM, Shanthikumar S, Hanna D, Cole T, and Neeland MR. "Elevated Plasma CXCL9 and CHI3L1 Prior to HCT Predict Post-HCT Lung Complications in Children." Clinical & Translational Immunology 14, no. 12 (2025): e70064. https://doi.org/10.1002/cti2.70064.

MLA (9th ed.) Citation

H, Walker, et al. "Elevated Plasma CXCL9 and CHI3L1 Prior to HCT Predict Post-HCT Lung Complications in Children." Clinical & Translational Immunology, vol. 14, no. 12, 2025, p. e70064, https://doi.org/10.1002/cti2.70064.